Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Tallman

Showing results (11-20 of 97) with videos related to

Pageof 10
Sort By:
Current Opinion in Oncology|January 1, 1995
Developments in the treatment of acute leukemia in adultsM D Volm, M S Tallman
Bone Marrow Transplantation|September 6, 2001
The role of bone marrow transplantation in acute promyelocytic leukemiaC Nabhan, J Mehta, M S Tallman
Blood Cancer Journal|April 18, 2015
Acute promyelocytic leukemia: where did we start, where are we now, and the futureC C Coombs, M Tavakkoli, M S Tallman
Blood|February 15, 1996
Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosineS Wheaton, M S Tallman, D Hakimian, et al.
Blood|September 15, 1993
Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemiaD Hakimian, M S Tallman, C Kiley, et al.
Annals of Internal Medicine|October 1, 1996
High-dose chemotherapy for breast cancerW J Gradishar, M S Tallman, J S Abrams
American Journal of Hematology|July 1, 1997
Hypocholesterolemia in hairy cell leukemia: a marker for proliferative activityJ Pandolfino, D Hakimian, A W Rademaker, et al.
Leukemia|May 1, 1993
Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemiaD Hakimian, M S Tallman, C Zugerman, et al.
Leukemia & Lymphoma|September 1, 1993
New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemiaM S Tallman, D Hakimian, H C Kwaan, et al.
Leukemia Research|October 15, 2020
Acute myeloid leukemia with 11q23 rearrangements: A study of therapy-related disease and therapeutic outcomesK Menghrajani, Y Zhang, C Famulare, et al.
Pageof 10

Showing results (11-20 of 97) with videos related to

Sort By:
Pageof 10
Current Opinion in Oncology|January 1, 1995
Developments in the treatment of acute leukemia in adultsM D Volm, M S Tallman
Bone Marrow Transplantation|September 6, 2001
The role of bone marrow transplantation in acute promyelocytic leukemiaC Nabhan, J Mehta, M S Tallman
Blood Cancer Journal|April 18, 2015
Acute promyelocytic leukemia: where did we start, where are we now, and the futureC C Coombs, M Tavakkoli, M S Tallman
Blood|February 15, 1996
Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosineS Wheaton, M S Tallman, D Hakimian, et al.
Blood|September 15, 1993
Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemiaD Hakimian, M S Tallman, C Kiley, et al.
Annals of Internal Medicine|October 1, 1996
High-dose chemotherapy for breast cancerW J Gradishar, M S Tallman, J S Abrams
American Journal of Hematology|July 1, 1997
Hypocholesterolemia in hairy cell leukemia: a marker for proliferative activityJ Pandolfino, D Hakimian, A W Rademaker, et al.
Leukemia|May 1, 1993
Erythema nodosum associated with all-trans-retinoic acid in the treatment of acute promyelocytic leukemiaD Hakimian, M S Tallman, C Zugerman, et al.
Leukemia & Lymphoma|September 1, 1993
New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemiaM S Tallman, D Hakimian, H C Kwaan, et al.
Leukemia Research|October 15, 2020
Acute myeloid leukemia with 11q23 rearrangements: A study of therapy-related disease and therapeutic outcomesK Menghrajani, Y Zhang, C Famulare, et al.
Pageof 10